Nitric oxide-releasing acetylsalicylic acid derivative
Jump to navigation
Jump to search
| Nitric oxide-releasing acetylsalicylic acid derivative | |
|---|---|
| Term | Nitric oxide-releasing acetylsalicylic acid derivative |
| Short definition | Niraparib Tosylate Monohydrate - (pronounced) (nih-RA-puh-rib TOH-suh-layt MAH-noh-HY-drayt) A drug used to treat adults with certain types of ovarian epithelial, fallopian tube, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Nitric oxide-releasing acetylsalicylic acid derivative - (pronounced) (NY-trik OK-side-reh-LEE-sing A-seh-til-SA-lih-SIH-lik A-sid deh-RIH-vuh-tiv) A substance being studied to prevent colon cancer. It is a form of aspirin that gives off nitric oxide gas and is less irritating to the stomach lining than pure aspirin. It is a type of nonsteroidal anti-inflammatory drug (NSAID). Also called NCX 4016
External links
- Medical encyclopedia article on Nitric oxide-releasing acetylsalicylic acid derivative
- Wikipedia's article - Nitric oxide-releasing acetylsalicylic acid derivative
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski